Teledermatology in the time of COVID-19
- PMID: 34714575
- PMCID: PMC8646275
- DOI: 10.1111/ijcp.15000
Teledermatology in the time of COVID-19
Abstract
Aims: The enormous spread of the novel Corona virus disease (COVID-19) represents a challenge to dermatological practice. Accumulating evidence has suggested a possible role of teledermatology in facing this challenge. In this article, we aimed to give a general overview of teledermatology in terms of models of practice, modes of delivery, advantages, limitations, ethical considerations and legislative challenges as well as discussing, using examples from literature, how dermatological practice can benefit from teledermatology during the time of the COVID-19 pandemic.
Discussion and conclusion: Teledermatology could be an accessible, accurate and cost-effective substitute for conventional face-to-face dermatological consultations during the COVID-19 pandemic. However, teledermatology practice needs updated legislation and guidelines. More efforts should be done to encourage dermatologists, especially in underserved communities, to provide teledermatology services. Ethical issues and data security related to teledermatology have to be considered.
© 2021 John Wiley & Sons Ltd.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
An Exploration of Dutch Dermatologists' Experience and Satisfaction With Teledermatology: Sociotechnical and Complex Adaptive System Perspective.JMIR Dermatol. 2024 Jul 26;7:e56723. doi: 10.2196/56723. JMIR Dermatol. 2024. PMID: 39059000 Free PMC article.
-
Inpatient teledermatology during the COVID-19 pandemic.J Dermatolog Treat. 2020 Aug;31(5):441-443. doi: 10.1080/09546634.2020.1762843. Epub 2020 May 13. J Dermatolog Treat. 2020. PMID: 32364809
-
Teledermatology in the times of COVID-19 - a systematic review.J Dtsch Dermatol Ges. 2020 Aug;18(8):841-845. doi: 10.1111/ddg.14180. Epub 2020 Jul 27. J Dtsch Dermatol Ges. 2020. PMID: 33448667
-
Utilization of Asynchronous and Synchronous Teledermatology in a Large Health Care System During the COVID-19 Pandemic.Telemed J E Health. 2021 Jul;27(7):771-777. doi: 10.1089/tmj.2020.0299. Epub 2020 Oct 19. Telemed J E Health. 2021. PMID: 33074786
-
Review of Teledermatology: Lessons Learned from the COVID-19 Pandemic.Am J Clin Dermatol. 2024 Jan;25(1):5-14. doi: 10.1007/s40257-023-00826-z. Epub 2023 Dec 7. Am J Clin Dermatol. 2024. PMID: 38062339 Review.
Cited by
-
Impact of an Evidence-Based Prioritization System and Electronic Consultation in Early Diagnosis of Colorectal Cancer.Healthcare (Basel). 2024 Jan 13;12(2):194. doi: 10.3390/healthcare12020194. Healthcare (Basel). 2024. PMID: 38255082 Free PMC article.
-
The Past, the Present and the Future of Teledermatology: A Narrative Review.Clin Cosmet Investig Dermatol. 2024 Mar 21;17:717-723. doi: 10.2147/CCID.S462799. eCollection 2024. Clin Cosmet Investig Dermatol. 2024. PMID: 38529172 Free PMC article. Review.
-
Inpatient Teledermatology: a Review.Curr Dermatol Rep. 2022;11(2):52-59. doi: 10.1007/s13671-022-00360-x. Epub 2022 Apr 2. Curr Dermatol Rep. 2022. PMID: 35402084 Free PMC article. Review.
-
The Impact of COVID-19 Vaccination on Inflammatory Skin Disorders and Other Cutaneous Diseases: A Review of the Published Literature.Viruses. 2023 Jun 23;15(7):1423. doi: 10.3390/v15071423. Viruses. 2023. PMID: 37515110 Free PMC article. Review.
-
Cutaneous Reactions Following COVID-19 Vaccination: A Review of the Current Literature.Clin Cosmet Investig Dermatol. 2022 Nov 6;15:2369-2382. doi: 10.2147/CCID.S388245. eCollection 2022. Clin Cosmet Investig Dermatol. 2022. PMID: 36387962 Free PMC article. Review.
References
-
- Recalcati S. Cutaneous manifestations in COVID‐19: a first perspective. J Eur Acad Dermatol Venereol. 2020;34(5):212‐213. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical